横田俊文・丸山理香・守山英則(共)編/ギャップマー:研究法・プロトコル(第2版)<br>Gapmers〈Second Edition 2026〉 : Methods and Protocols

個数:1
紙書籍版価格
¥45,470
  • 電子書籍

横田俊文・丸山理香・守山英則(共)編/ギャップマー:研究法・プロトコル(第2版)
Gapmers〈Second Edition 2026〉 : Methods and Protocols

  • 言語:ENG
  • ISBN:9781071654750
  • eISBN:9781071654767

ファイル: /

Description

This new edition reflects the progression of gapmer research from conceptual foundations to experimental implementation and analytical detection. Beginning with a section covering historical perspectives and the clinical context of antisense gapmers, the book continues with molecular design principles, experimental strategies for developing effective antisense oligonucleotides, methods to evaluate their efficacy and selectivity in cellular and animal models, and analytical approaches for detecting and quantifying antisense oligonucleotides in biological samples. Written for the highly successful Methods in Molecular Biology series, chapters include the kind of detailed implementation advice needed to ensure success in the lab.


Authoritative and up-to-date, Gapmers: Methods and Protocols, Second Edition serves as a valuable resource for researchers and clinicians aiming to accelerate the development of next-generation antisense therapeutics.

Table of Contents

Gapmers: Invention and Early History.- Development and Clinical Applications of Antisense Oligonucleotide Gapmers.- Knocking Down Long Non-Coding RNAs Using Antisense Oligonucleotide Gapmers.- Development of Antisense Gapmers for the Treatment of Huntington’s Disease.- Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy.- Olezarsen for the Treatment of Hypertriglyceridemia.- Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis.- Eplontersen for the Treatment of Hereditary Transthyretin Amyloidosis.- Using Antisense Oligonucleotides for the Degradation of Toxic RNA in Myotonic Dystrophy Type 1.- Development of Antisense Oligonucleotide Gapmers for Amyotrophic Lateral Sclerosis.- DNA/RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.- LncRNA Knockdown Using Gapmer Antisense Oligonucleotides.- Evaluating the Knockdown Activity of MALAT1 ENA Gapmers In Vitro.- Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics.- Screening and Evaluation Scheme for the Identification of Antisense Oligonucleotides with Antiviral Activity Against SARS-CoV-2.- Gapmer and Mixmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy.- Viral RNA-Targeting Locked Nucleic Acid Gapmers: Design and In Vitro Evaluation.- Tissue Pharmacokinetics of Antisense Oligonucleotides.- Detection of Locked Nucleic Acid and 2’-O-Methoxyethyl Gapmers from Mouse Samples Using ELISA.

最近チェックした商品